
Endpoints
Claim This Podcastby ALS TDI
Podcast Authority
Beta
Podcast Overview
<p>The <a href="https://www.als.net/endpoints/">Endpoints Podcast</a> features guests from the ALS community, including people living with ALS, researchers, advocates and fundraisers. <strong>Each episode cuts to the chase with short, digestible conversations</strong> about the latest <strong>research at ALS TDI</strong> and the most closely watched <strong>ALS clinical trials</strong> as well as <strong>stories from people living with ALS</strong> with their thoughts on research, healthcare and their journey with ALS.</p> <p>The Endpoints Podcast is hosted by the <a href="https://www.als.net">ALS Therapy Development Institute (ALS TDI)</a> the world's foremost <strong>drug discovery lab </strong>focused <strong>solely on ALS. ALS TDI is a non-profit biotech with one mission. End ALS.</strong></p> <p>To access all episodes of the Endpoints Podcast, visit als.net/endpoints.</p>
Language
🇺🇲
Publishing Since
9/18/2019
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for Endpoints
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

September 5, 2025
Your Story, Our Science: Her ALS Story and ALS TDI Bring Together Science and Lived Experience
<p>Nobody knows ALS better than people living with the disease. Therefore, it’s crucial for scientists to utilize the perspectives of people with lived experience in their research.</p> <p>Earlier this year, ALS TDI joined with <strong>Her ALS Story</strong>—a group of women diagnosed with ALS before the age of 35—to put on a series of Town Hall webinars that highlighted the importance of this connection. The three-part series featured discussions about ALS risk factors, lesser-known symptoms, and stories of diagnosis. In each session, researchers from ALS TDI’s ALS Research Collaborative, or <strong>ARC Study</strong>, presented information about our current scientific understanding of each topic, while Her ALS Story members shared their own personal experiences.</p> <p>Today, on Endpoints, we’ll hear some highlights from each episode of the series. We’ll also be joined by Dr. Danielle Boyce, ALS TDI’s Principal Investigator, Real World Evidence, and Alan Premasiri, our Director of Clinical Operations, to discuss what they learned from the discussions and how conversations like these can help shape the way they approach their research.</p> <p><strong>If you'd like to learn more about ALS TDI's research and how we are incorporating lived experience to advance research, consider attending the ALS TDI Summit on October 17th, 2025 in Boston, MA or online. Register here: </strong><strong><a href="https://fundraise.als.net/alssummit/">https://fundraise.als.net/alssummit/</a></strong></p><p><a href="https://www.als.net/donate/" rel="payment">Support the show: https://www.als.net/donate/</a></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>

August 14, 2025
How Brain Computer Interfaces (BCIs) Could Help People with ALS Communicate
<p dir="ltr">Brain-computer interfaces, or BCIs, aim to enable people to control various adaptive devices directly with their thoughts. There are many BCI devices currently in various stages of development, with the potential to help people with ALS and similar conditions across many different activities of daily life.</p> <p dir="ltr">One particular area in which BCI devices may be able to support people with advanced ALS symptoms is communication. Many people with ALS rely on devices such as smartphones, tablets, and laptops to write or speak. All tools like these, collectively known as augmentative and alternative communication or AAC devices, need some kind of input to work. </p> <p dir="ltr">This could mean using a keyboard, a touchscreen, or, for people with advanced paralysis, an eye-gaze device. As ALS progresses, however, even eye gaze devices may become difficult for some people to use. BCIs—by allowing people to control AAC devices with their minds—could be a potential solution to this problem. </p> <p dir="ltr">Today, on Endpoints, we’re joined by two experts to discuss BCI technology and, in particular, its potential to help people with ALS continue to communicate.</p> <p>The views expressed in this podcast are those of the speakers and do not represent official endorsements by any organization. Kate Nilsen currently serves as an advisor to Synchron, a company developing a brain-computer interface (BCI) device. This device is investigational and is currently in clinical trials approved by the U.S. Food and Drug Administration (FDA). For those interested in staying informed about Synchron’s ongoing work and updates, please join the Synchron community: <a href="https://link.edgepilot.com/s/4239f747/ca21cbCpKkOSLI5ZXNqTdQ?u=https://www.synchronbci.com/StayConnected.html" data-linkindex="4" data-ogsc="">https://link.edgepilot.com/s/4239f747/ca21cbCpKkOSLI5ZXNqTdQ?u=https://www.synchronbci.com/StayConnected.html</a></p><p><a href="https://www.als.net/donate/" rel="payment">Support the show: https://www.als.net/donate/</a></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>

February 20, 2025
The Power of Big Data in ALS: Dr. Danielle Boyce
<p>Today on <strong>Endpoints,</strong> Dr. Danielle Boyce joins us to explore how data science is transforming our understanding of ALS and why the ALS Research Collaborative (ARC) Study presents an exciting opportunity for research.</p> <p>As ALS TDI’s <strong>Principal Investigator for Real-World Evidence</strong>, Dr. Boyce brings extensive expertise in analyzing big data to uncover key insights about ALS. Her work focuses on harnessing the vast amount of information collected through ALS TDI’s <strong>ARC Study, </strong>turning data into discoveries that could drive ALS research forward.</p><p><a href="https://www.als.net/donate/" rel="payment">Support the show: https://www.als.net/donate/</a></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
67 total episodes available with 8 transcripts
Deep-dive analytics for Endpoints
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Endpoints?
<p>The <a href="https://www.als.net/endpoints/">Endpoints Podcast</a> features guests from the ALS community, including people living with ALS, researchers, advocates and fundraisers. <strong>Each episode cuts to the chase with short, digestible conversations</strong> about the latest <strong>research at ALS TDI</strong> and the most closely watched <strong>ALS clinical trials</strong> as well as <strong>stories from people living with ALS</strong> with their thoughts on research, healthcare and their journey with ALS.</p> <p>The Endpoints Podcast is hosted by the <a href="https://www.als.net">ALS Therapy Development Institute (ALS TDI)</a> the world's foremost <strong>drug discovery lab </strong>focused <strong>solely on ALS. ALS TDI is a non-profit biotech with one mission. End ALS.</strong></p> <p>To access all episodes of the Endpoints Podcast, visit als.net/endpoints.</p> - How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.